Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference29 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009
3. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N Engl J Med,2009
4. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP;Yun;Proc Natl Acad Sci U S A,2008
5. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors;Sequist;Sci Transl Med,2011
Cited by 186 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer;Frontiers in Oncology;2024-08-26
2. Radical resection in a patient with stage IIIA non-small cell lung cancer with the EGFR exon 19 deletion mutation after neoadjuvant targeted therapy with osimertinib: a case report;Translational Lung Cancer Research;2024-06
3. From Rarity to Reality: Osimertinib’s Promising Horizon in Treating Uncommon EGFR Mutations in Non–Small Cell Lung Cancer;Clinical Cancer Research;2024-05-20
4. Complex situations in lung cancer: multifocal disease, oligoprogression and oligorecurrence;European Respiratory Review;2024-04-30
5. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors;Clinical Radiology;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3